首页> 外文期刊>Hospital pharmacy. >Current FDA-Related Drug InformationApprovals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals
【24h】

Current FDA-Related Drug InformationApprovals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals

机译:当前与FDA相关的药品信息批准,提交以及美国市场上药品的重要标签变更

获取原文
获取原文并翻译 | 示例
       

摘要

This monthly feature will help readers keep current on new drugs, new indications, dosage forms, and safety-related changes in labeling or use. Efforts have been made to ensure the accuracy of this information; however, if there are any questions, please let me know at bakerdan@wsu.edu.
机译:该月度功能将帮助读者了解新药,新适应症,剂型以及与安全性有关的标签或用途变化。已努力确保此信息的准确性;但是,如果有任何疑问,请通过bakerdan@wsu.edu与我联系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号